Company Search:
Advanced Search
Sponsored Links
Irlab Therapeutics Ab Company Snapshot
Irlab Therapeutics Ab operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Irlab Therapeutics Ab with three other pharmaceutical manufacturers in Europe: Oasmia Pharmaceutical AB (2017 sales of 172,000.00 Swedish Kronor [US$19,210.68 ] ), Index Pharmaceuticals Holding Ab (113,000.00 Swedish Kronor [US$12,620.97 ] ), and Infant Bacterial Therapeutics AB (238,000.00 Swedish Kronor [US$26,582.22 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Irlab Therapeutics Ab
  Stock Performance Chart for Irlab Therapeutics Ab
  Stock Data: Recent Stock Performance:
  Current Price (10/12/2018): 302.00
(Figures in Swedish Kronor)
1 Week -11.2%   13 Weeks -1.6%  
4 Weeks 37.3%   52 Weeks 110.8%  
Irlab Therapeutics Ab Key Data:
  Ticker: IRLAB A Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 109,000
(Year Ending Jan 2018).
Employees: 22
  Currency: Swedish Kronor Market Cap: 2,446,181,578
  Fiscal Yr Ends: December Shares Outstanding: 8,099,939
  Share Type: Aktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.